N

Nanobiotix SA
D

NBTX

5.40000
USD
-0.22
(-3.91%)
Market Closed
Volume
8
EPS
0
Div Yield
0
P/E
-5
Market Cap
207,632,731
OverviewSignalsIdeasNews
Related Instruments
    AZN
    2.040
    (2.58%)
    81.200 USD
    BMY
    0.620
    (1.30%)
    48.180 USD
    GILD
    0.470
    (0.62%)
    76.510 USD
    GSK
    0.865
    (2.23%)
    39.650 USD
    JNJ
    2.930
    (1.86%)
    160.770 USD
    LLY
    28.47
    (3.54%)
    832.74 USD
    MRK
    0.680
    (0.60%)
    113.800 USD
    NVO
    -0.070
    (-0.05%)
    132.560 USD
    PFE
    0.115
    (0.38%)
    30.650 USD
    SNY
    -0.090
    (-0.17%)
    51.700 USD
News

Title: Nanobiotix SA

Sector: Healthcare
Industry: Biotechnology
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.